Ramy Farid - Feb 2, 2023 Form 3 Insider Report for Structure Therapeutics Inc. (GPCR)

Role
Director
Signature
Jun Yoon, Attorney-in-Fact
Stock symbol
GPCR
Transactions as of
Feb 2, 2023
Transactions value $
$0
Form type
3
Date filed
2/2/2023, 05:24 PM
Previous filing
Jan 5, 2023
Next filing
Feb 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GPCR Ordinary Shares 2.62M Feb 2, 2023 By Schrodinger, Inc. F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GPCR Series B Preferred Shares Feb 2, 2023 Ordinary Shares 642K By Schrodinger, Inc. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is President, Chief Executive Officer and a member of the board of directors of Schrodinger, Inc. ("Schrodinger") and may be deemed to share voting and dispositive power over the shares held by Schrodinger. The Reporting Person disclaims beneficial ownership of the shares held by Schrodinger.
F2 All outstanding Preferred Shares will automatically convert into Ordinary Shares immediately upon the closing of Issuer's initial public offering, for no additional consideration at a rate of one Ordinary Share for each one Preferred Share, based on the conversion price currently in effect. The Preferred Shares have no expiration date.